Malaria RTS,S Vaccine from China
Recombinant circumsporozoite protein-based vaccine with AS01 adjuvant for Plasmodium falciparum. HTS 3002.49.0050 as other protozoal culture-derived prophylactic.
Duty Rate — China → United States
100%
Rate breakdown
9903.04.60100%Pharmaceuticals: patented pharma articles — 100% floor rate
9903.05.860%Universal product exemption (U.S. note 52(b))
9903.05.900%Articles already subject to Section 232 (steel/aluminum/copper + derivatives, autos + parts, wood, medium/heavy vehicles + parts, semiconductors, patented pharma) — U.S. note 52(f)
Import Tips
• Declare adjuvant composition; multi-dose vial stability data
• Endemic import quotas may apply; CDC collaboration proof
• Reclass risk if adjuvant dominant to 3003